BackDIVA Laboratories, Overview

DIVA Laboratories, Receivables

Track DIVA Laboratories,'s receivables ($310M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$311.60M
↑ 7.37% YoYΔ $21.39M vs prior year quarter

Peer trimmed avg / median

Loading

DIVA Laboratories, Receivables History

Loading

DIVA Laboratories, vs. peers: Receivables Comparison

Loading

DIVA Laboratories, Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

DIVA Laboratories, (4153.TWO) FAQ

DIVA Laboratories, posts a receivables of $310M as of June 2026. That compares with $290M in the prior-year period — up 7.4% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, DIVA Laboratories,'s receivables was $290M. The latest reading is $310M — a 7.4% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Receivables is one piece of DIVA Laboratories,'s financial statement story. At $310M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 4153.TWO's receivables usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; DIVA Laboratories,'s other metric pages and overview cover the third.